Red Cell forms Zephyr AI

By The Science Advisory Board staff writers

November 23, 2021 -- Red Cell has formed Zephyr AI to transform drug discovery and precision medicine through the integration of artificial intelligence (AI).

Zephyr integrates AI with extensive datasets discover new therapies, applications for existing therapeutics, and advanced biomarkers for individualized treatments.

The company is co-founded by Yisroel Brumer, PhD, formerly of the Office of the Secretary of Defense; Grant Verstandig, former CEO of Rally Health; and Jeff Sherman, former machine learning architect at Rally Health.


Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter